1. Discovery and Diagnostics Analyst Team
U.S. Point-of-Care Retail Diagnostics Markets Ease-of-use and Forceful Marketing Expected to Drive OTC Tests and Monitors Markets
“Simple designs that aid convenience, accessibility, facility of interpretation, and instant results are major factors driving demand for OTC pregnancy and ovulation tests as well as cholesterol tests and monitors.”
Discovery and Diagnostics Analyst Team
Frost & Sullivan

2. Industry Trends
The ovulation market will continue to focus on technological innovations to increase brand name recognition and market share
Marketing strategies will target key consumers of ovulation products to maximize benefit of limited marketing dollars
Pregnancy test manufactures will continue claim driven marketing strategies to differentiate products that are largely perceived as commodities by consumers
At-home cholesterol tests and monitors will experience substantial sales increases as the public accepts the health risks associated with elevated cholesterol

3. Key Features Frost & Sullivan provides:
Detailed insights into recent developments
Analysis of market, technology, and end-user trends
Drivers, restraints, challenges, and strategic recommendations
Analyst insights on technological innovations
Market sizing and competitive structure analysis
Market forecasts and opportunity analysis

4. What We Offer Coverage of the Clinical Diagnostic Industry
Proven methodology encompassing extensive primary and secondary data and research
Focused information and strategies that cover business and technology issues
Credible data and analysis highlighting industry dynamics
Winning strategies to help you create precise business plans

5. Who Will Benefit? Current Market Participants
Find out how you compare to the competition
Assess current and future drivers and restraints
Determine and exploit new market share opportunities
New Entrants
Analyze challenges associated with the industry
Calculate time scales for strategy implementation
Position yourself to capitalize on the market’s unmet needs
Investment Community
Analyze long-term strategies of clinical diagnostic companies
Determine which participants will outperform the competition
Assess attractiveness of investing in the clinical diagnostic industry

6. What’s Included Market & technology trends and developments
Forecast model integrating a bottom-up approach with
demand side penetration analysis
Business models and alliance opportunities
Incorporation of end user feedback in analysis
Overview of competitive landscape and key success factors
Analysis of firms likely to excel in the market
Frost & Sullivan’s Market Engineering Analysis

7. Key Market Participants
Abbott Laboratories/ Ross Products Div.
AccuTech LLC
Acon Laboratories, Inc.
AmeriTek, Inc.
Armkel LLC(Church & Dwight Co.)
Chmeatics, Inc.
Choletech Corp.
Cortez Diagnostics, Inc.
Genzyme Diagnostics
Germaine Laboratories, Inc.
Home Access Health Corp.
Inverness Medical Ltd.
Lifestream Technologies, Inc.
Perrigo Co.
Pfizer, Inc.
Pheromone Sciences Corp.
Phamatech, Inc.
Polymer Technology Systems, Inc.
Princeton BioMeditech Corp.
Quidel Corp.
SA Scientific, Inc.
Scantibodies Laboratory, Inc.
Syntron, Inc.
Zetek, Inc.

8. For More Information Call toll free 877 GO FROST (877.463.7876)
Fax toll free
Visit